Concepts and core principles of fragment-based drug design

156Citations
Citations of this article
484Readers
Mendeley users who have this article in their library.

Abstract

In this review, a general introduction to fragment-based drug design and the underlying concepts is given. General considerations and methodologies ranging from library selection/construction over biophysical screening and evaluation methods to in-depth hit qualification and subsequent optimization strategies are discussed. These principles can be generally applied to most classes of drug targets. The examples given for fragment growing, merging, and linking strategies at the end of the review are set in the fields of enzyme-inhibitor design and macromolecule-macromolecule interaction inhibition. Building upon the foundation of fragment-based drug discovery (FBDD) and its methodologies, we also highlight a few new trends in FBDD.

Cite

CITATION STYLE

APA

Kirsch, P., Hartman, A. M., Hirsch, A. K. H., & Empting, M. (2019, November 26). Concepts and core principles of fragment-based drug design. Molecules. MDPI AG. https://doi.org/10.3390/molecules24234309

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free